Levamisole-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis in paediatric nephrotic syndrome: dose-dependent and idiosyncratic risks in paediatric patients.
Two pediatric cases of levamisole-induced vasculitis are reported, highlighting the risks associated with this medication in managing nephrotic syndrome.
Clinical pearl
Clinicians should be vigilant for signs of levamisole-induced autoimmunity in pediatric patients, as it can occur with both dose escalation and prolonged therapy.